Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide

Ryan T Nitta; Sara Bolin; Emily Luo; David E Solow-Cordero; Peyman Samghabadi; Teresa Purzner; Parvir S Aujla; Ginikachi Nwagbo; Yoon-Jae Cho; Gordon Li

doi:10.1038/s41388-019-1077-y

Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide

Oncogene. 2020 Feb;39(9):2029. doi: 10.1038/s41388-019-1077-y.

Authors

Affiliations

¹ Department of Neurosurgery, Stanford University, Stanford, CA, USA. [email protected].
² Department of Neurosurgery, Stanford University, Stanford, CA, USA.
³ High-Throughput Bioscience Center, Department of Chemical and Systems Biology, Stanford University, Stanford, CA, USA.
⁴ Department of Neuropathology, Stanford University, Stanford, CA, USA.
⁵ Department of Developmental Biology, Stanford University, Stanford, CA, USA.
⁶ Division of Neurosurgery, University of Toronto, Toronto, ON, Canada.
⁷ Department of Pediatrics, Papé Family Pediatric Research Institute, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

Abstract

The original version of this Article contained an error in the spelling of the author David Solow-Cordero, which was incorrectly given as David Solow-Codero. This has now been corrected in both the PDF and HTML versions of the Article.

Publication types

Published Erratum